{"transactions":[{"id":1811298,"issuer":{"id":7313,"kind":"organization","name":"MILESTONE SCIENTIFIC INC."},"owners":[{"id":110685,"kind":"person","name":"Milligan Peter J","position":1,"cik":"0001531049","reported_name":"Milligan Peter J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Common Stock, Par Value $0.001","published_at":"2023-08-10T23:28:10.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":46296,"price":1.08,"value":49999.68,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"124,421 of these shares are issuable to the reporting person at the termination of employment"}],"balance_after":124421,"source":{"system":"sec-edgar","filing":"0001437749-23-023148","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855683/000143774923023148/rdgdoc.xml","form_type":"4"}},{"id":3518428,"issuer":{"id":154249,"kind":"organization","name":"MELINTA THERAPEUTICS, INC. /NEW/","symbol":"MLNT"},"owners":[{"id":110685,"kind":"person","name":"Milligan Peter J","position":1,"cik":"0001531049","reported_name":"Milligan Peter J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2019-05-20T20:21:28.000Z","date":"2019-05-16","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units will vest in equal semi-annual installments over the two year period following May 16, 2019, subject to Mr. Milligan's continued service with the Issuer through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units will vest in equal semi-annual installments over the two year period following May 16, 2019, subject to Mr. Milligan's continued service with the Issuer through the applicable vesting date."}],"balance_after":150000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000899243-19-014223","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1461993/000089924319014223/doc4.xml","form_type":"4"}},{"id":3808173,"issuer":{"id":154249,"kind":"organization","name":"MELINTA THERAPEUTICS, INC. /NEW/","symbol":"MLNT"},"owners":[{"id":110685,"kind":"person","name":"Milligan Peter J","position":1,"cik":"0001531049","reported_name":"Milligan Peter J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-09-25T18:05:56.000Z","date":"2018-09-21","kind":"grant","acquired":true,"shares":370000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-quarter of the options will vest and become exercisable on September 17, 2019 and the remainder will vest and become exercisable in substantially equal monthly installments during the three year period commencing on September 17, 2019, subject to Mr. Milligan's continued service with the Company through the applicable vesting date."}],"balance_after":370000,"derivative":{"exercise_price":4.5,"expiration_date":"2028-09-21","underlying":"Common Stock","underlying_shares":370000},"source":{"system":"sec-edgar","filing":"0000899243-18-025192","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1461993/000089924318025192/doc4.xml","form_type":"4"}}]}